Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF 10F
NM
-
GSK923295
CENPE
Kinesin
7871.001
uM
0.05773
0.05552
-0.3537 0.0328 1.7394 0.4399
0.8919
1.0311
MCF 10F
NM
-
Ibandronate
FDPS
12254.143
uM
177.1340
398.44880
-0.0080 -0.3886 0.7093 0.1825
0.9772
1.4110
MCF 10F
NM
-
ICRF-193
TOP2
TOP
12254.157
uM
inf
0.08854
0.8275 0.8456 4.9373 0.0612
0.9149
1.6969
MCF 10F
NM
-
IKK16
IKK
NFKB
7486.1
uM
3.82890
5.00590
-0.9988 -0.9986 4.0953 0.3766
0.9977
1.0281
MCF 10F
NM
-
Imatinib
ABL/KIT/PDGFR
nRTK
7486.092
uM
9.76170
22.29110
-0.9978 -1.0000 1.3305 0.5043
0.9957
1.1266
MCF 10F
NM
-
Imatinib
ABL/KIT/PDGFR
nRTK
7487.09
uM
39.39260
56.10840
-0.9891 -0.9905 3.0881 0.3364
0.9984
1.5226
MCF 10F
NM
-
Ispinesib
KSP
Kinesin
7487.067
uM
0.03384
0.45356
-0.9677 -1.0000 0.4233 0.6721
0.8878
1.3523
MCF 10F
NM
-
Ixabepilone
TUBB
TUBB
7486.095
uM
0.00829
0.10436
-0.9993 -1.0000 0.4338 0.9187
0.9127
0.9448
MCF 10F
NM
-
JNK-IN-5A
JNK
JNK
12254.144
uM
inf
inf
0.8974 0.8974 0.0000 0.0190
0.2706
1.8842
MCF 10F
NM
-
L-779450
BRAF
MAPK
12254.161
uM
14.10120
16.03370
-0.4145 -0.4208 4.7543 0.1039
0.9948
1.3991
MCF 10F
NM
-
Lapatinib
EGFR/HER2
ErbB
7486.098
uM
13.11290
16.15790
-0.0393 -0.9204 5.0000 0.0412
0.9871
0.9165
MCF 10F
NM
-
LBH589
HDAC
HDAC
12254.154
uM
0.93382
1.34260
-0.6126 -0.5614 2.0731 0.3518
0.9942
1.6307
MCF 10F
NM
-
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12254.154
uM
2.04870
3.43670
-0.7731 -0.8008 1.8482 0.3182
0.9927
1.6307
MCF 10F
NM
-
Mebendazole
13750.174
uM
3.91920
96.55890
-0.0155 -1.0000 0.3429 0.2885
0.9278
1.4282
MCF 10F
NM
-
Methotrexate
DHFR
Metabolism
7487.084
uM
0.09336
0.07754
0.2750 0.3024 5.0000 0.4595
0.9971
1.3396
MCF 10F
NM
-
Methylglyoxal
13672.184
uM
325.82880
1000.00000
-0.9500 -0.9161 0.9284 0.6111
0.9793
2.3721
MCF 10F
NM
-
MG-132
Proteasome
Proteasome
14161.189
uM
0.07893
0.11362
-0.9316 -0.5920 2.1442 0.8378
0.8784
1.1003
MCF 10F
NM
-
MG-132
Proteasome
Proteasome
14161.189
uM
0.07893
0.11362
-0.9316 -0.5920 2.1442 0.8378
0.8784
1.1003
MCF 10F
NM
-
MG-132
Proteasome
Proteasome
12254.145
uM
0.08265
0.17690
-0.7329 -0.7389 1.1924 0.7782
0.9946
1.7869
MCF 10F
NM
-
MG-132
Proteasome
Proteasome
12254.145
uM
0.08265
0.17690
-0.7329 -0.7389 1.1924 0.7782
0.9946
1.7869
MCF 10F
NM
-
Pevonedistat
NAE1
NAE1
12254.135
uM
0.74058
0.71573
0.0331 0.0139 0.8259 0.3490
0.9943
1.6637
MCF 10F
NM
-
Nelfinavir
13750.174
uM
9.41490
15.28370
-0.7109 -1.0000 2.2675 0.2028
0.9819
1.4282
MCF 10F
NM
-
Nilotinib
ABL
nRTK
12254.145
uM
inf
inf
0.8912 0.8912 0.0000 0.0017
0.4681
1.7869
MCF 10F
NM
-
NSC 663284
CDC25
CDC
12254.152
uM
2.78020
5.66370
-0.8559 -0.9155 1.4624 0.5340
0.9964
1.8382
MCF 10F
NM
-
NU6102
CDK1/2
CDK
12254.147
uM
12.25660
19.72940
-0.9129 -1.0000 2.3078 0.1912
0.9898
1.4316